APPLICATION
ANDA210766
TYPE
ANDA
ORIGINAL APPROVAL
2019-03-29
LATEST ACTION
2020-11-02
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 40MEQ/15ML · SOLUTION · ORAL
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 20MEQ/15ML · SOLUTION · ORAL
Approval history
2020-11-02Labeling · Supplement 4 · standardAP
2019-08-08Labeling · Supplement 2 · standardAP
2019-03-29UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.